Caroline Hammer

988 total citations
15 papers, 350 citations indexed

About

Caroline Hammer is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Caroline Hammer has authored 15 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Caroline Hammer's work include Lipid Membrane Structure and Behavior (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Caroline Hammer is often cited by papers focused on Lipid Membrane Structure and Behavior (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Caroline Hammer collaborates with scholars based in Switzerland, Germany and Austria. Caroline Hammer's co-authors include Ernst R. Waelti, Hans‐Peter Marti, Gérald Tuffin, Jörg Huwyler, Inti Zlobec, Alessandro Lugli, Eva Karamitopoulou, Mary Economou, Heather Dawson and Viktor H. Koelzer and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Society of Nephrology and International Journal of Cancer.

In The Last Decade

Caroline Hammer

15 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline Hammer Switzerland	10	170	122	61	60	50	15	350
Chad E. Galer United States	12	125 0.7×	138 1.1×	69 1.1×	41 0.7×	55 1.1×	16	365
Michal Mauda‐Havakuk United States	9	106 0.6×	53 0.4×	35 0.6×	36 0.6×	59 1.2×	27	424
Michele Gottardi Italy	13	136 0.8×	202 1.7×	57 0.9×	63 1.1×	35 0.7×	37	579
Erin F. Cobain United States	11	168 1.0×	90 0.7×	128 2.1×	29 0.5×	69 1.4×	35	390
Joanna E. Richards United States	10	263 1.5×	180 1.5×	32 0.5×	125 2.1×	29 0.6×	11	441
Petra Aigner Austria	6	153 0.9×	103 0.8×	38 0.6×	28 0.5×	39 0.8×	8	372
Dagmar Eleveld-Trancikova Netherlands	9	254 1.5×	151 1.2×	43 0.7×	34 0.6×	48 1.0×	10	466
Sang Woo Juhng South Korea	12	94 0.6×	97 0.8×	47 0.8×	50 0.8×	96 1.9×	24	352
Benjia Liang China	12	189 1.1×	152 1.2×	77 1.3×	14 0.2×	26 0.5×	17	398

Countries citing papers authored by Caroline Hammer

Since Specialization

Citations

This map shows the geographic impact of Caroline Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Hammer more than expected).

Fields of papers citing papers by Caroline Hammer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Hammer. The network helps show where Caroline Hammer may publish in the future.

Co-authorship network of co-authors of Caroline Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Hammer. A scholar is included among the top collaborators of Caroline Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Hammer. Caroline Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Blank, Annika, et al.. (2022). Real‐life data from standardized preanalytical coding (SPREC) in tissue biobanking and its dual use for sample characterization and process optimization. The Journal of Pathology Clinical Research. 9(2). 137–148. 3 indexed citations

Hewer, Ekkehard, et al.. (2017). Implementation of a ‘lean’ cytopathology service: towards routine same-day reporting. Journal of Clinical Pathology. 71(5). 395–401. 2 indexed citations

Hammer, Caroline, et al.. (2017). Lean-Management im Pathologielabor. Der Pathologe. 38(6). 540–544. 7 indexed citations

Eichhorn, Tanja, Sabine Rauscher, Caroline Hammer, et al.. (2016). Polystyrene-Divinylbenzene-Based Adsorbents Reduce Endothelial Activation and Monocyte Adhesion Under Septic Conditions in a Pore Size-Dependent Manner. Inflammation. 39(5). 1737–1746. 16 indexed citations

Eichhorn, Tanja, et al.. (2015). Cell-culture model to study endothelial activation in sepsis. Critical Care. 19(S1). 1 indexed citations

Dawson, Heather, Viktor H. Koelzer, Eva Karamitopoulou, et al.. (2013). The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome. Histopathology. 64(4). 577–584. 47 indexed citations

Dawson, Heather, José A. Galván, Eva Karamitopoulou, et al.. (2013). Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. International Journal of Cancer. 134(10). 2342–2351. 52 indexed citations

Wilkens, Ludwig, et al.. (2012). Hepatocellular and Cholangiolar Carcinoma-Derived Cell Lines Reveal Distinct Sets of Chromosomal Imbalances. Pathobiology. 79(3). 115–126. 7 indexed citations

Wilkens, Ludwig, Rolf Jaggi, Caroline Hammer, et al.. (2011). The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(6). 697–708. 17 indexed citations

10.

Tuffin, Gérald, Jörg Huwyler, Ernst R. Waelti, Caroline Hammer, & Hans‐Peter Marti. (2008). Drug targeting using OX7-immunoliposomes: Correlation between Thy1.1 antigen expression and tissue distribution in the rat. Journal of drug targeting. 16(2). 156–166. 9 indexed citations

11.

Hammer, Caroline, et al.. (2007). Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2. Journal of drug targeting. 15(9). 623–631. 26 indexed citations

12.

Tuffin, Gérald, Ernst R. Waelti, Jörg Huwyler, Caroline Hammer, & Hans‐Peter Marti. (2005). Immunoliposome Targeting to Mesangial Cells. Journal of the American Society of Nephrology. 16(11). 3295–3305. 64 indexed citations

13.

Riess, Hanno, A. Helm, Marco Niedergethmann, et al.. (2005). A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer. Journal of Clinical Oncology. 23(16_suppl). LBA4009–LBA4009. 80 indexed citations

14.

Gregson, Norman A. & Caroline Hammer. (1982). Some immunological properties of antisera raised against the trisialoganglioside GT1b. Molecular Immunology. 19(4). 543–550. 10 indexed citations

15.

Gregson, Norman A. & Caroline Hammer. (1980). Antibodies against Defined Nerve Cell Components: Gangliosides. Journal of the Royal Society of Medicine. 73(7). 501–504. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact